FOXK2 and ovarian carcinoma: Building on the initial findings, we extended our investigation to determine the synergistic effect of ZrTCP@siFOXK2 NPs with metformin, given that prior studies confirmed the ability of metformin to enhance the inhibitory effect of FOXK2 siRNA on ovarian cancer cells.